MET and renal cell adenocarcinoma: Research has indicated that exosome-mediated transfer of lncARSR promotes the expression of AXL and c-MET in RCC cells by competitively binding to miR-34/miR-449, thereby contributing to the development of resistance to sunitinib [90].